文献速递生殖医学

透明质酸联合催乳素用于冻融囊胚移植的随机对照试验

Post-warming culture and single vitrified-warmed blastocyst transfer with hyaluronic acid and prolactin: a randomized controlled trial.
PubMed 文献 · Reprod Biomed Online · 2025-11-18

这项三臂双盲随机对照试验纳入1236对接受单囊胚冻融移植的夫妇,比较去透明带后使用普通培养基、含透明质酸培养基或含透明质酸联合催乳素培养基孵育2-4小时的活产率。结果显示联合催乳素组活产率高于对照组和透明质酸组,且继续妊娠率更高、早期妊娠丢失率更低。亚组分析提示该效果在培养第4-5天囊胚和血清孕酮不足患者中显著。

要点

  • 透明质酸联合催乳素孵育可提高冻融单囊胚移植的活产率
  • 联合组继续妊娠率更高且早期妊娠丢失率更低
  • 效果在培养第4-5天囊胚和血清孕酮不足患者中显著

核心结论

  • 透明质酸联合催乳素处理可提高预后良好患者单囊胚冻融移植的活产率,机制可能与减少早期妊娠丢失有关。

研究设计与样本

  • 去透明带后囊胚分别用无透明质酸和催乳素的培养基、含透明质酸培养基或含透明质酸联合催乳素培养基孵育2-4小时后移植。

主要发现

  • 联合催乳素组活产率高于对照组(OR 1.40;P = 0.0219)和透明质酸组(OR 1.38;P = 0.0266)。
  • 三组阳性妊娠率和临床妊娠率相当,但联合组继续妊娠率高于对照组(P = 0.0142)和透明质酸组(P = 0.0249)。
  • 联合组早期妊娠丢失率低于对照组(P = 0.0073)和透明质酸组(P = 0.0053)。
  • 亚组分析显示胚胎培养时间(P = 0.0494)和血清孕酮(P = 0.0045)存在显著交互作用,联合处理对第4-5天囊胚和血清孕酮不足患者有效。

关键数值与推荐

  • 主要结局为活产率,联合催乳素组活产率较对照组OR 1.40(P = 0.0219),较透明质酸组OR 1.38(P = 0.0266)。
  • 继续妊娠率联合组高于对照组(P = 0.0142)和透明质酸组(P = 0.0249)。
  • 早期妊娠丢失率联合组低于对照组(P = 0.0073)和透明质酸组(P = 0.0053)。

临床怎么用

  • 对于预后良好的单囊胚冻融移植患者,可考虑去透明带后使用透明质酸联合催乳素孵育2-4小时以提高活产率。
  • 该处理对培养第4-5天囊胚和血清孕酮不足患者可能获益更明显。

局限性

  • 研究仅纳入预后良好患者,结论外推需谨慎。
  • 亚组分析结果需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Does combined treatment with hyaluronic acid and prolactin (PRL) for post-warming culture and embryo transfer increase the live birth rate after single vitrified-warmed blastocyst transfer (SVBT)? DESIGN: A three-arm, double-blind, randomized controlled trial (RCT) was conducted between October 2020 and May 2021. Overall, 1236 couples undergoing SVBT were randomized using a 1:1:1 ratio into three groups: after removing the zona pellucida, warmed blastocysts were incubated in a medium without hyaluronic acid or PRL (control group), a hyaluronic-acid-enriched transfer medium (EmbryoGlue group), or EmbryoGlue supplemented with PRL (EGP group) for 2-4 h prior to transfer in the same medium. The primary outcome was the live birth rate. RESULTS: The live birth rate was higher in the EGP group compared with the control (OR 1.40; P = 0.0219) and EmbryoGlue (OR 1.38; P = 0.0266) groups. Although positive pregnancy and clinical pregnancy rates were comparable among the three groups, the ongoing pregnancy rate was higher in the EGP group compared with the control (P = 0.0142) and EmbryoGlue (P = 0.0249) groups. Furthermore, the rate of early pregnancy loss was lower in the EGP group compared with the control (P = 0.0073) and EmbryoGlue (P = 0.0053) groups. Subgroup analysis demonstrated significant interactions for embryo culture time (P = 0.0494) and serum progesterone (P = 0.0045): EGP treatment was effective for day 4-5 blastocysts and patients with insufficient serum progesterone. CONCLUSIONS: This RCT suggests that combined treatment with hyaluronic acid and PRL is effective for improving the live birth rate in good-prognosis patients by reducing early pregnancy loss.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Ezoe K, Miki T, Fujiwara N, et al. Post-warming culture and single vitrified-warmed blastocyst transfer with hyaluronic acid and prolactin: a randomized controlled trial. Reprod Biomed Online. 2025. PMID: 41806715. doi:10.1016/j.rbmo.2025.105417

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。